Chemclin Diagnostics Co., Ltd. (SHA:688468)
China · Delayed Price · Currency is CNY 7.39
+0.15 (2.07%)
Apr 29, 2026, 2:45 PM CST
Chemclin Diagnostics Revenue
In the year 2025, Chemclin Diagnostics had annual revenue of 332.68M CNY, down -23.75%. Chemclin Diagnostics had revenue of 71.86M in the quarter ending December 31, 2025, a decrease of -22.32%.
Revenue
332.68M
Revenue Growth
-23.75%
P/S Ratio
8.59
Revenue / Employee
528.90K
Employees
606
Market Cap
2.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 332.68M | -103.61M | -23.75% |
| Dec 31, 2024 | 436.29M | -9.05M | -2.03% |
| Dec 31, 2023 | 445.34M | -19.93M | -4.28% |
| Dec 31, 2022 | 465.27M | -5.50M | -1.17% |
| Dec 31, 2021 | 470.77M | 52.57M | 12.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maccura Biotechnology Co.Ltd | 2.21B |
| Medicalsystem Biotechnology | 1.54B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.20B |
| Berry Genomics Co.,Ltd | 941.16M |
| SMO ClinPlus CO.,LTD. | 819.09M |